This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by KLING, M. A. Articles by GOLD, P. W. Search for Related Content PubMed PubMed Citation Articles by KLING, M. A. Articles by GOLD, P. W. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Cushing's Syndrome Hazardous Substances DB HYDROCORTISONE

Cerebrospinal Fluid Immunoreactive Cortieotropin-Releasing Hormone and Adrenocorticotropin Secretion in Cushing's Disease and Major Depression: Potential Clinical Implications

Clinical Neuroendocrinology Branch (M.A.K., J.R.C., H.J.W., P.W.G.), Clinical Neurosciences Branch (A.R., A.R.D.), and Biological Psychiatry Branch (D.R.R., R.M.P.), National Institute of Mental Health; Laboratory of Neurosciences, National Institute on Aging (CM.); and Developmental Endocrinology Branch, National Institute of Child Health and Human Development (G.P.C.), National Institutes of Health Bethesda, Maryland 20892

Address all correspondence and requests for reprints to: Mitchel A. Kling, M.D., Chief, Unit on Affective Disorders, Clinical Neuroendocrinology Branch, National Institute on Mental Health/Division of Intramural Research Programs, National Institutes of Health Clinical Center, 9000 Rockville Pike, Building 10, Room 3S-231, Bethesda, Maryland 20892.

To explore whether possible differences in central nervous system neuromodulators contribute to the differential presentation of affective symptomatology in Cushing's disease and major depression, we examined the levels of immu-noreactive CRH and ACTH in the cerebrospinal fluid (CSF) of 11 patients with Cushing's disease, a patient with ectopic ACTH secretion, 34 patients with major depression, and 60 healthy subjects. We elected to measure these peptides not only because both are classically involved in pituitary-adrenal regulation, but also because their primarily arousal-producing and anorexigenic behavioral effects in experimental animals suggest that they may play a role in the symptom complex of depressive syndromes. We also explored whether the CSF levels of these peptides were more helpful in determining the often difficult differential diagnosis between major depression and Cushing's disease than the plasma ACTH response to ovine CRH, a currently used but somewhat insensitive laboratory means of distinguishing these disorders. CSF levels of immunoreactive CRH and ACTH were significantly lower in Cushing's disease patients [21.9 ± 2.7 and 15.4 ± 1.8 pg/mL, (mean ± SEM), respectively] compared to patients with major depression [38.4 ± 2.3 pg/mL (P < 0.01) and 5:4.5 ± 1.6 pg/mL (P < 0.01), respectively] and controls [38.4 ± 1.6 pg/mL (P < 0.001) and 26.3 ± 1.1 pg/mL (P < 0.001), respectively]. The coexistence of high plasma ACTH and low CSF ACTH in Cushing's disease yielded a CSF/plasma ACTH ratio consistently less than that in depressed patients, with only 2 of 31 subjects comprising both groups showing values that overlapped. In contrast, 9 of the combined patients showed ACTH responses to ovine CRH that overlapped. These data suggest that differences in centrally directed CRH secretion may account for the differential presentation of the dysphoric syndromes seen in major depression and Cushing's disease. Hence, the classic form of major depression (melancholia), is often associated with evidence of pathological hyperarousal, such as intense anxiety, sleeplessness, and anorexia, while that of Cushing's disease is associated with evidence of pathological hyposrousal, including hyperphagia, fatigue, and inertia. Moreover, measurement of the CSF/plasma ACTH ratio may serve as a clinically useful adjunct to the ovine CRH stimulation test and other laboratory measures in determining the differential diagnosis between major depression and Cushing's disease.

Received April 23, 1990.

This article has been cited by other articles:

				M. Mazza, M. Di Nicola, G. D. Marca, L. Janiri, P. Bria, and S. Mazza Bipolar Disorder and Epilepsy: A Bidirectional Relation? Neurobiological Underpinnings, Current Hypotheses, and Future Research Directions Neuroscientist, August 1, 2007; 13(4): 392 - 404. [Abstract] [PDF]

				T. M. Buckley and A. F. Schatzberg On the Interactions of the Hypothalamic-Pituitary-Adrenal (HPA) Axis and Sleep: Normal HPA Axis Activity and Circadian Rhythm, Exemplary Sleep Disorders J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 3106 - 3114. [Abstract] [Full Text] [PDF]

				D. P. Merke, J. N. Giedd, M. F. Keil, S. L. Mehlinger, E. A. Wiggs, S. Holzer, E. Rawson, A. C. Vaituzis, C. A. Stratakis, and G. P. Chrousos Children Experience Cognitive Decline Despite Reversal of Brain Atrophy One Year After Resolution of Cushing Syndrome J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2531 - 2536. [Abstract] [Full Text] [PDF]

				Z. Merali, L. Du, P. Hrdina, M. Palkovits, G. Faludi, M. O. Poulter, and H. Anisman Dysregulation in the Suicide Brain: mRNA Expression of Corticotropin-Releasing Hormone Receptors and GABAA Receptor Subunits in Frontal Cortical Brain Region J. Neurosci., February 11, 2004; 24(6): 1478 - 1485. [Abstract] [Full Text] [PDF]

				Z.'e. Hochberg, K. Pacak, and G. P. Chrousos Endocrine Withdrawal Syndromes Endocr. Rev., August 1, 2003; 24(4): 523 - 538. [Abstract] [Full Text] [PDF]

				E. M. Strome, G. H. T. Wheler, J. D. Higley, D. L. Loriaux, S. J. Suomi, and D. J. Doudet Intracerebroventricular corticotropin-releasing factor increases limbic glucose metabolism and has social context-dependent behavioral effects in nonhuman primates PNAS, November 26, 2002; 99(24): 15749 - 15754. [Abstract] [Full Text] [PDF]

				R. C. Daly, T.-P. Su, P. J. Schmidt, D. Pickar, D. L. Murphy, and D. R. Rubinow Cerebrospinal Fluid and Behavioral Changes After Methyltestosterone Administration: Preliminary Findings Arch Gen Psychiatry, February 1, 2001; 58(2): 172 - 177. [Abstract] [Full Text] [PDF]

				M.-L. Wong, M. A. Kling, P. J. Munson, S. Listwak, J. Licinio, P. Prolo, B. Karp, I. E. McCutcheon, T. D. Geracioti Jr., M. D. DeBellis, et al. Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: Relation to hypercortisolism and corticotropin-releasing hormone PNAS, January 4, 2000; 97(1): 325 - 330. [Abstract] [Full Text] [PDF]

				O. M. Wolkowitz and V. I. Reus Treatment of Depression With Antiglucocorticoid Drugs Psychosom Med, September 1, 1999; 61(5): 698 - 711. [Abstract] [Full Text] [PDF]

				G. P. Chrousos and P. W. Gold A Healthy Body in a Healthy Mind--and Vice Versa--The Damaging Power of "Uncontrollable" Stress J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 1842 - 1845. [Full Text]

				J. A. Yanovski, L. K. Nieman, J. L. Doppman, G. P. Chrousos, R. L. Wilder, P. W. Gold, and K. T. Kalogeras Plasma Levels of Corticotropin-Releasing Hormone in the Inferior Petrosal Sinuses of Healthy Volunteers, Patients with Cushing's Syndrome, and Patients with Pseudo-Cushing States J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1485 - 1488. [Abstract] [Full Text]

				G. P. Chrousos Editorial: Ultradian, Circadian, and Stress-Related Hypothalamic-Pituitary-Adrenal Axis Activity--A Dynamic Digital-to-Analog Modulation Endocrinology, February 1, 1998; 139(2): 437 - 440. [Full Text] [PDF]

				L. D. Dorn, E. S. Burgess, T. C. Friedman, B. Dubbert, P. W. Gold, and G. P. Chrousos The Longitudinal Course of Psychopathology in Cushing's Syndrome after Correction of Hypercortisolism J. Clin. Endocrinol. Metab., March 1, 1997; 82(3): 912 - 919. [Abstract] [Full Text] [PDF]

				M. Virkkunen, R. Rawlings, R. Tokola, R. E. Poland, A. Guidotti, C. Nemeroff, G. Bissette, K. Kalogeras, S.-L. Karonen, and M. Linnoila CSF Biochemistries, Glucose Metabolism, and Diurnal Activity Rhythms in Alcoholic, Violent Offenders, Fire Setters, and Healthy Volunteers Arch Gen Psychiatry, January 1, 1994; 51(1): 20 - 27. [Abstract] [PDF]

				E. M. Sternberg, G. P. Chrousos, R. L. Wilder, and P. W. Gold The Stress Response and the Regulation of Inflammatory Disease Ann Intern Med, November 15, 1992; 117(10): 854 - 866. [Abstract] [PDF]

				G. P. Chrousos and P. W. Gold The Concepts of Stress and Stress System Disorders: Overview of Physical and Behavioral Homeostasis JAMA, March 4, 1992; 267(9): 1244 - 1252. [Abstract] [PDF]